According to biology, a pluripotent cell has the ability to differentiate into three of the available germ layers. Induced pluripotency is a man-created process of converting non-pluripotent cells into those with pluripotent abilities. These induced pluripotent stem cells are of great interest in the current medical and research fields. These are commonly also called as iPSCs and have the ability to propagate as many times as needed. They promise to play an important role in regenerative medicine science.
The fact that such induced pluripotent stem cells can be used to create complete transplantation tissues and organs is one of the main advantages of this field. This is also a reason why different research centers are spending enormous money on working with these cells. These cells, when handled right can also play a very important role in the biopharmaceutical fields. With the use of these cells, different potentially useful drugs can also be discovered.
This report is a detailed analysis of the global induced pluripotent stem cells market and how it is posed to grow in the coming years. The high cost of researching and handling these cells is considered a potential restraint for the market growth. Similar to this, different restraints and risk factors are discussed in the report. It also goes on to talk about the opportunities the market will create for different stakeholders. Vital values like revenues generated, CAGR, sales volume and demand and supply of these cells are identified.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820086-induced-pluripotent-stem-cells-global-markets
There are different categories of cells and their applications that the report analyzes. Based on the types of induced pluripotent stem cells, the report deals with cardiomyocytes, neurons, hepatocytes, and endothelia cells. Depending on the different product functions that these cells relate to, types like cellular reprogramming, molecular and cellular engineering, cell culture, cell analysis, and cell differentiation are investigated. The potential demand for each of these functions is explained. Based on the application areas, demand in the drug development and toxicity testing, academic research, and regenerative medicine fields are studied.
This report uses data from the years 2015 and 2016 to forecast the growth of the global induced pluripotent stem cells market up to the year 2021. The different regions included in this study are Europe, the USA, Asia-Pacific and the Rest of the World (ROW). The report goes on to identify the areas that are market leaders in the research and usage of these stem cells. It also identifies the regions that will provide the highest revenue in this industry. Submarkets created in these regions are identified too and their potential scopes for growth are explained.
Based on the results of a study published in the Nature Biotechnology journal in March 2019, a group of researchers from the USA has managed to provide hypo immunogenic features to iPSCs to prevent them from being attacked by the immune system. This is a breakthrough in this industry.
Mentioned Key Player Profiles:
Abm (Applied Biological Materials Inc.), Addgene, Allele Biotechnology And Pharmaceuticals Inc., Alstem Llc, Applied Stemcell Inc., Atcc, Axiogenesis Ag, Axol Biosciencee, Bio-Techne, Bluerock Therapeutics, Bristol-Myers Squibb (Ipierian), Cell Signaling Technology, Cellular Dynamics International, A Fujifilm Company, Corning Life Sciences, Creative Bioarray, Emd Millipore, Fate Therapeutics, Genecopoeia, Gentarget Inc., Id Pharma Co. Ltd., Invivogen, Lonza Group Ltd., Mello Biotechnology Inc., Mti-Globalstem, Newcells Biotech, Opsis Therapeutics, Orig3n Inc., Peprotech, Plasticell Ltd., Pluriomics B.V., Primorigen Biosciences, Promega Corp., Promocell Gmbh, Qiagen N.V., Reprocell Inc., Roslin Cell Sciences, Sciencell Research Laboratories, Sigma-Aldrich, A Part Of Milliporesigma, Stem Cell Theranostics Inc., Stemcell Technologies, Stemgent Inc., A Reprocell Group Company, System Biosciences Inc., Takara Bio Usa Inc. (Clontech Laboratories), Thermo Fisher Scientific, Viacyte Inc., Waisman Biomanufacturing
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Overview
Chapter 4 Induced Pluripotent Stem Cell Applications
Chapter 5 Induced Pluripotent Stem Cell Market Segmentation and Forecast
Chapter 6 Induced Pluripotent Stem Cell Research Application Market
Chapter 7 Drug Discovery and Development Market
Chapter 8 Induced Pluripotent Stem Cell Contract Service Market
Chapter 9 Induced Pluripotent Stem Cell Clinical Application Market
Chapter 10 Research Market Trend Analysis
Chapter 11 Clinical Application Market Trend Analysis
Chapter 12 Company Profiles
Chapter 13 Conclusions
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349